NO975527D0 - Use of alendronate to prevent osteoporosis - Google Patents

Use of alendronate to prevent osteoporosis

Info

Publication number
NO975527D0
NO975527D0 NO975527A NO975527A NO975527D0 NO 975527 D0 NO975527 D0 NO 975527D0 NO 975527 A NO975527 A NO 975527A NO 975527 A NO975527 A NO 975527A NO 975527 D0 NO975527 D0 NO 975527D0
Authority
NO
Norway
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
NO975527A
Other languages
Norwegian (no)
Other versions
NO975527L (en
Inventor
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO975527D0 publication Critical patent/NO975527D0/en
Publication of NO975527L publication Critical patent/NO975527L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO975527A 1995-06-02 1997-12-01 Use of alendronate to prevent osteoporosis NO975527L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
NO975527D0 true NO975527D0 (en) 1997-12-01
NO975527L NO975527L (en) 1997-12-01

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975527A NO975527L (en) 1995-06-02 1997-12-01 Use of alendronate to prevent osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527L (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
EP1392325B1 (en) * 2001-05-02 2006-06-21 Novartis AG Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
JPH10506648A (en) 1998-06-30
BG63103B1 (en) 2001-04-30
CN1192685A (en) 1998-09-09
NZ308935A (en) 2000-07-28
TR199701482T1 (en) 1998-03-21
IL118422A0 (en) 1996-09-12
KR19990022436A (en) 1999-03-25
EE03306B1 (en) 2000-12-15
CA2222318A1 (en) 1996-12-05
AU709196B2 (en) 1999-08-26
EA000677B1 (en) 2000-02-28
AU5882496A (en) 1996-12-18
ZA964465B (en) 1996-12-11
WO1996038156A1 (en) 1996-12-05
BG102060A (en) 1998-07-31
HUP9900659A3 (en) 2002-12-28
EA199700449A1 (en) 1998-06-25
HUP9900659A2 (en) 2001-04-28
BR9609020A (en) 1999-07-06
IS4617A (en) 1997-11-19
EP0828496A1 (en) 1998-03-18
NO975527L (en) 1997-12-01
CZ381197A3 (en) 1998-06-17
PL323669A1 (en) 1998-04-14
SK159597A3 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
DK0770615T3 (en) Process for the preparation of dihalogenazolopyrimidines
DE69633333D1 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC SUBSTANCES
DE69604788D1 (en) HYDROSILYLATION OF UNSATURATED COMPOUNDS
NO950760D0 (en) Process for the preparation of alkyl halosilanes
ID19439A (en) IMPROVEMENT OF ORGANIC COMPOUNDS OR RELATED
NO952986D0 (en) Device for the mutual attachment of two devices
IT1276799B1 (en) FORMULATIONS OF F-SILICONE
NO975527D0 (en) Use of alendronate to prevent osteoporosis
ID17424A (en) INHIBITION OF METALOPROTEASA MATRIX BY SUBSTITUTED FENETYL COMPOUNDS
NO980862D0 (en) Zwitterinoforms of trovafloxacin
DK0721929T3 (en) Process for the preparation of hydroxyalkoxybenzophenones
NO995750D0 (en) Process for the preparation of a deoxyuridine derivative
DK0863874T3 (en) Process for the preparation of dioxoazabicyclohexanes
NO964685L (en) Isomization of equilin
PT761766E (en) ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE
KR970000111U (en) 3rd phase transfer of the metropolitan equipment system
AT204U3 (en) FOOT SCRAPER
KR970010637U (en) Switchgear of water distributor
KR970036510U (en) Modulator fixing structure of ABS system
SE9503245D0 (en) Preparation of optocomponent plate
NO955296D0 (en) Process for the preparation of concrete construction
FI950265A (en) Wall of element construction
NO973476D0 (en) Process for the preparation of alkyl halosilanes
NO945058D0 (en) Use of phosphonates for the treatment of osteoporosis
KR970005433A (en) How to determine the flange length of the panel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application